PROTAGONIST THERAPEUTICS INC

Ticker: PTGX CUSIP: 74366E102 Class: Common Stock

J. Goldman & Co LP's Holding History (CIK: 0001412741)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025

Shares 46,325 Value ($000) $4,046 Avg Close $81.85 Range $62.24 - $96.54

Q3 2025

Shares 18,068 Value ($000) $1,200 Avg Close $56.84 Range $49.38 - $68.26

Q2 2025

Shares 35,828 Value ($000) $1,980 Avg Close $47.99 Range $39.60 - $57.70

Q1 2025

Shares 65,244 Value ($000) $3,155 Avg Close $41.90 Range $33.70 - $60.60

Q1 2022

Shares 81,873 Value ($000) $1,939 Avg Close $28.17 Range $22.56 - $37.05

Q4 2021

Shares 130,517 Value ($000) $4,464 Avg Close $31.61 Range $17.26 - $38.11

Q2 2021

Shares 19,986 Value ($000) $897 Avg Close $33.01 Range $24.14 - $45.93

Q1 2021

Shares 49,579 Value ($000) $1,284 Avg Close $25.31 Range $18.82 - $32.10

Q4 2020

Shares 38,341 Value ($000) $773 Avg Close $21.52 Range $17.44 - $25.65

Q3 2020

Shares 23,216 Value ($000) $454 Avg Close $18.76 Range $14.16 - $23.25

Q2 2020

Shares 49,359 Value ($000) $872 Avg Close $12.55 Range $6.00 - $19.67

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2025	46,325	$4,046	$81.85	$62.24 - $96.54
Q3 2025	18,068	$1,200	$56.84	$49.38 - $68.26
Q2 2025	35,828	$1,980	$47.99	$39.60 - $57.70
Q1 2025	65,244	$3,155	$41.90	$33.70 - $60.60
Q1 2022	81,873	$1,939	$28.17	$22.56 - $37.05
Q4 2021	130,517	$4,464	$31.61	$17.26 - $38.11
Q2 2021	19,986	$897	$33.01	$24.14 - $45.93
Q1 2021	49,579	$1,284	$25.31	$18.82 - $32.10
Q4 2020	38,341	$773	$21.52	$17.44 - $25.65
Q3 2020	23,216	$454	$18.76	$14.16 - $23.25
Q2 2020	49,359	$872	$12.55	$6.00 - $19.67